中国药物经济学2024，Vol.19Issue(3)：19-24,6.DOI:10.12010/j.issn.1673-5846.2024.03.003
基于决策树模型的坤泰胶囊治疗更年期综合征的药物经济学评价
Pharmacoeconomic Evaluation of Kuntai Capsule in the Treatment of Menopausal Syndrome based on Decision Tree Model
王福平 1刘毅 1崔鑫 1谢雁鸣1
作者信息
- 1. 中国中医科学院中医临床基础医学研究所,北京 100700
- 折叠
摘要
Abstract
Objective To assess the cost-effectiveness of KunTai capsules in treating menopausal syndrome(MS).Methods Meta analysis of Kuntai capsule in MS treatment was searched in Chinese and English databases such as Chinese journal full-text database,Wanfang Data Knowledge Service Platform,International Health Technology Evaluation Agency Network(INAHTA)and EMBASE,and an economic evaluation model of Kuntai capsule in MS treatment was constructed from the perspective of health system to evaluate the economy of Kuntai capsule.Results In this paper,a meta-analysis is included and Treeage Pro software is used to construct a decision tree model.The results show that:The cost and health outcomes of Kuntai capsule combined with hormone therapy for MS 90 d were higher than those of hormone therapy alone,and the incremental cost-effectiveness ratio(ICER)was 170.65 yuan,that is,compared with hormone therapy alone,it cost 170.65 yuan more to improve Kupperman by using Kuntai capsule for each additional 1 minute.Assuming a patient's WTP threshold of 2022 per capita disposable income,Kuntai capsule combined with hormone regimens is more economical than hormone regimens alone.The results of sensitivity analysis show that the results of basic analysis are robust.Conclusion KunTai capsules combined with hormone therapy is more cost-effective than hormone therapy alone in terms of Kupperman symptom score.关键词
药物经济学/决策树模型/坤泰胶囊/上市后评价/更年期综合征Key words
Pharmacoeconomics/Decision tree model/Kuntai capsule/Post-marketing evaluation/Menopausal syndrome分类
医药卫生引用本文复制引用
王福平,刘毅,崔鑫,谢雁鸣..基于决策树模型的坤泰胶囊治疗更年期综合征的药物经济学评价[J].中国药物经济学,2024,19(3):19-24,6.
